Search research articles
Contact Us
Filters
Showing results (161-170 of 179) with videos related to
Page
of 18
Sort By:
Journal of Affective Disorders
|
March 23, 2016
Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression
Lina Quteineh, Martin Preisig, Margarita Rivera, et al.
Mayo Clinic Proceedings
|
September 28, 2021
Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies
Dusan Petrovic, Menno Pruijm, Belén Ponte, et al.
Human Molecular Genetics
|
April 12, 2012
Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension
Idris Guessous, Maria Dobrinas, Zoltán Kutalik, et al.
Nature Communications
|
February 6, 2026
Inhibition of stress resilience and adult hippocampal neurogenesis by platelet-derived LPA16:0 in anxiety
Thomas Larrieu, Fabio Grieco, Charline Carron, et al.
Journal of Clinical Lipidology
|
November 13, 2017
Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia
Aurélie Delacrétaz, Frederik Vandenberghe, Mehdi Gholam-Rezaee, et al.
JAMA Psychiatry
|
August 9, 2013
Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population
Eva Choong, Lina Quteineh, Jean-René Cardinaux, et al.
British Journal of Clinical Pharmacology
|
March 13, 2020
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk
Etienne Weisskopf, Monia Guidi, Céline J Fischer, et al.
Schizophrenia Bulletin
|
February 21, 2018
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
Philippe Conus, Larry J Seidman, Margot Fournier, et al.
British Journal of Clinical Pharmacology
|
July 20, 2024
A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION project
Anaëlle Monfort, Evelina Cardoso, Chin B Eap, et al.
Molecular Psychiatry
|
September 17, 2025
Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses
Nermine Laaboub, Frederik Vandenberghe, Nicolas Ansermot, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 179) with videos related to
Sort By:
Page
of 18
Journal of Affective Disorders
|
March 23, 2016
Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression
Lina Quteineh, Martin Preisig, Margarita Rivera, et al.
Mayo Clinic Proceedings
|
September 28, 2021
Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies
Dusan Petrovic, Menno Pruijm, Belén Ponte, et al.
Human Molecular Genetics
|
April 12, 2012
Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension
Idris Guessous, Maria Dobrinas, Zoltán Kutalik, et al.
Nature Communications
|
February 6, 2026
Inhibition of stress resilience and adult hippocampal neurogenesis by platelet-derived LPA16:0 in anxiety
Thomas Larrieu, Fabio Grieco, Charline Carron, et al.
Journal of Clinical Lipidology
|
November 13, 2017
Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia
Aurélie Delacrétaz, Frederik Vandenberghe, Mehdi Gholam-Rezaee, et al.
JAMA Psychiatry
|
August 9, 2013
Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population
Eva Choong, Lina Quteineh, Jean-René Cardinaux, et al.
British Journal of Clinical Pharmacology
|
March 13, 2020
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk
Etienne Weisskopf, Monia Guidi, Céline J Fischer, et al.
Schizophrenia Bulletin
|
February 21, 2018
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
Philippe Conus, Larry J Seidman, Margot Fournier, et al.
British Journal of Clinical Pharmacology
|
July 20, 2024
A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION project
Anaëlle Monfort, Evelina Cardoso, Chin B Eap, et al.
Molecular Psychiatry
|
September 17, 2025
Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses
Nermine Laaboub, Frederik Vandenberghe, Nicolas Ansermot, et al.
Page
of 18